384 related articles for article (PubMed ID: 30940203)
1. Could the menagerie of the gut microbiome really cure cancer? Hope or hype.
Abid MB
J Immunother Cancer; 2019 Apr; 7(1):92. PubMed ID: 30940203
[TBL] [Abstract][Full Text] [Related]
2. Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments.
Brandi G; Frega G
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159348
[TBL] [Abstract][Full Text] [Related]
3. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
[TBL] [Abstract][Full Text] [Related]
4. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome and cancer immunotherapy.
Li W; Deng Y; Chu Q; Zhang P
Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome and CAR-T therapy.
Abid MB; Shah NN; Maatman TC; Hari PN
Exp Hematol Oncol; 2019; 8():31. PubMed ID: 31827982
[TBL] [Abstract][Full Text] [Related]
7. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
Matson V; Chervin CS; Gajewski TF
Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
[TBL] [Abstract][Full Text] [Related]
8. Manipulating the microbiome to improve the efficacy of immunotherapy.
Gajewski T
Clin Adv Hematol Oncol; 2016 Jun; 14(6):424-6. PubMed ID: 27379811
[No Abstract] [Full Text] [Related]
9. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches.
Hazra R; Chattopadhyay S; Mallick A; Gayen S; Roy S
Med Oncol; 2024 Jun; 41(7):175. PubMed ID: 38874788
[TBL] [Abstract][Full Text] [Related]
10. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
11. The Gut Microbiome and Pediatric Cancer: Current Research and Gaps in Knowledge.
Bhuta R; Nieder M; Jubelirer T; Ladas EJ
J Natl Cancer Inst Monogr; 2019 Sep; 2019(54):169-173. PubMed ID: 31532533
[TBL] [Abstract][Full Text] [Related]
12. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
Front Immunol; 2018; 9():946. PubMed ID: 29780391
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome and adaptive immunity in schizophrenia.
Agorastos A; Bozikas VP
Psychiatriki; 2019; 30(3):189-192. PubMed ID: 31685450
[TBL] [Abstract][Full Text] [Related]
14. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
[TBL] [Abstract][Full Text] [Related]
15. The Impact of the Fecal Microbiome on Cancer Immunotherapy.
Osman AEG; Luke JJ
BioDrugs; 2019 Feb; 33(1):1-7. PubMed ID: 30604388
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
Singh A; Alexander SG; Martin S
Front Immunol; 2023; 14():1114499. PubMed ID: 37261348
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
Pandey P; Khan F
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Effect of Antibiotics and Microbial Metabolites on Expanded Vδ2Vγ9 T Cells in Hepatocellular Carcinoma Immunotherapy.
Han J; Zhang S; Xu Y; Pang Y; Zhang X; Hu Y; Chen H; Chen W; Zhang J; He W
Front Immunol; 2020; 11():1380. PubMed ID: 32849498
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer.
Temraz S; Nassar F; Nasr R; Charafeddine M; Mukherji D; Shamseddine A
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450712
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.
Guven DC; Aktas BY; Simsek C; Aksoy S
Future Oncol; 2020 Mar; 16(9):497-506. PubMed ID: 32100550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
